.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Artificial-intelligence systems can assist physicians with imaging interpretation, risk prediction and clinical decision support, but evidence from implementation research shows that performance in controlled datasets does not automatically translate to better patient care. Model drift, differences between hospitals, missing data and alert fatigue can reduce real-world utility. For internists, the key design principle is human-in-the-loop care: AI should surface patterns or prioritize attention while clinicians verify the result against the patient's history, examination and treatment context. Monitoring is also necessary after deployment to detect changes in accuracy and unexpected biases. This is particularly important in high-stakes situations such as sepsis, chest pain or medication decisions. The strongest use cases are those in which AI addresses a specific bottleneck and its output can be independently checked. APICON's focus on “AI versus clinical judgment” is therefore best framed as augmentation rather than replacement: the future system should make clinicians faster and more consistent without transferring accountability away from the medical team.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Artificial-intelligence systems can assist physicians with imaging interpretation, risk prediction and clinical decision support, but evidence from implementation research shows that performance in controlled datasets does not automatically translate to better patient care. Model drift, differences between hospitals, missing data and alert fatigue can reduce real-world utility. For internists, the key design principle is human-in-the-loop care: AI should surface patterns or prioritize attention while clinicians verify the result against the patient's history, examination and treatment context. Monitoring is also necessary after deployment to detect changes in accuracy and unexpected biases. This is particularly important in high-stakes situations such as sepsis, chest pain or medication decisions. The strongest use cases are those in which AI addresses a specific bottleneck and its output can be independently checked. APICON's focus on “AI versus clinical judgment” is therefore best framed as augmentation rather than replacement: the future system should make clinicians faster and more consistent without transferring accountability away from the medical team.
3 weeks back
Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month
Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back
